• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ADVANCED STERILIZATION PRODUCTS US CIDEX® OPA SOLUTION; BIOCIDES SOLUTIONS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ADVANCED STERILIZATION PRODUCTS US CIDEX® OPA SOLUTION; BIOCIDES SOLUTIONS Back to Search Results
Catalog Number 20390
Device Problem Use of Device Problem (1670)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/10/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
A customer reported they are not testing their cidex® opa solution for the minimum effective concentration (mec) prior to use and the affected loads are being released for use to patients.There are no known injuries or infections reported as a result of the issue.The cidex® opa solution instructions for use (ifu) states that cidex® opa test strips should be used prior to each use to test for the mec.It states, ¿do not rely solely on days in use.Concentration of this product during its reuse life must be verified by the cidex® opa solution test strip prior to each use to determine that the concentration of ortho-phthalaldehyde is above the mec of 0.3%.The product must be discarded after 14 days, even if the cidex opa solution test strip indicates a concentration above the mec.¿ asp has determined that in this situation, high level disinfection cannot be assured.Therefore, asp has decided to report all incidents as a matter of policy if the loads have been released without reprocessing.The customer was advised to always test the cidex® opa solution prior to each use.A copy of the instructions for use (ifu) for both the cidex® opa solution and the cidex® opa solution test strip was sent to the customer.
 
Manufacturer Narrative
The investigation included a review of the batch history record, complaint trending and system risk analysis (sra).The batch history record could not be reviewed as the lot number was not available.Complaint trending by lot number could not be performed as the lot number was not available.The sra indicates the risk associated with exposure to biohazardous, pathogenic or infectious material is "low." the likely assignable cause of this issue was failure to follow instructions.A copy of the instructions for use (ifu) for both the cidex opa solution and the cidex opa solution test strip was sent to the customer.The issue will continue to be tracked and trended.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
US CIDEX® OPA SOLUTION
Type of Device
BIOCIDES SOLUTIONS
Manufacturer (Section D)
ADVANCED STERILIZATION PRODUCTS
33 technology drive
irvine CA 92618
MDR Report Key7558700
MDR Text Key109769725
Report Number2084725-2018-00608
Device Sequence Number1
Product Code MED
UDI-Device Identifier10705037000074
UDI-Public10705037000074
Combination Product (y/n)N
PMA/PMN Number
K991487
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 05/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number20390
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/10/2018
Initial Date FDA Received05/31/2018
Supplement Dates Manufacturer Received11/21/2018
Supplement Dates FDA Received12/10/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-